scispace - formally typeset
J

Jun Mimuro

Researcher at Jichi Medical University

Publications -  90
Citations -  2791

Jun Mimuro is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Plasminogen activator & Fibrinolysis. The author has an hindex of 26, co-authored 90 publications receiving 2618 citations. Previous affiliations of Jun Mimuro include Mitsubishi.

Papers
More filters
Journal ArticleDOI

Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

TL;DR: Deep molecular weight forms of ADAMTS13 were found in the plasma of patients with sepsis-induced DIC, suggesting that the deficiency of ADamTS13 was partially caused by its cleavage by proteases in addition to decreased synthesis in the liver.
Journal ArticleDOI

Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury.

TL;DR: It is found that sphingosine 1‐phosphate (Sph‐1‐P), a physiological lysophospholipid mediator, had a potent chemoattractant activity for NSPCs, in which, of Sph‐ 1‐P receptors, S1P1 was abundantly expressed.
Journal ArticleDOI

Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitor

TL;DR: Three monoclonal antibodies to alpha 2-plasmin inhibitor (alpha 2PI) were characterized and results suggested that the antibody recognized an epitope near the N terminus, useful for analyzing the mechanism of interaction between alpha 2PI and plasmin.
Journal ArticleDOI

Il2rg Gene-Targeted Severe Combined Immunodeficiency Pigs

TL;DR: The generation and preliminary evaluation of a porcine SCID model of severe combined immunodeficiency pigs represent a step toward the comprehensive evaluation of preclinical cellular regenerative strategies.
Journal ArticleDOI

Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.

TL;DR: Aspirin resistance expressed as unsuppressed platelet COX‐1 activity is a rare condition in an out‐patient population and the existence of diabetes mellitus was an independent risk factor for overall outcomes.